Table 3.
Urinary hepcidin (nM.mmol Cr
−1
) |
p-values |
Effect sizes |
|||||||
---|---|---|---|---|---|---|---|---|---|
T0 | T3 | Trial | Time | Interaction | T0-T3 | T0: RTB-CTB | T3: RTB-CTB | ||
Day 1 |
RTB |
0.46 |
1.19a |
0.179 |
0.002 |
0.014 |
1.68 |
0.15 |
0.68 |
(0.14) |
(0.26) |
||||||||
CTB |
0.52 |
0.64b |
0.63 |
||||||
(0.06) |
(0.10) |
||||||||
Day 2 |
RTB |
0.76c |
1.38 |
0.524 |
0.245 |
0.190 |
0.99 |
0.14 |
0.54 |
(0.20) |
(0.37) |
||||||||
CTB |
0.85 |
0.84 |
0.02 |
||||||
(0.24) |
(0.28) |
||||||||
Day 6 |
RTB |
0.71 |
0.93 |
0.173 | 0.171 | 0.505 | 1.69 |
0.29 | 0.25 |
(0.04) |
(0.16) |
||||||||
CTB | 0.43 |
0.80 |
0.99 | ||||||
(0.12) | (0.28) |
aSignificantly different to T0.
bSignificantly different to RTB Day 1, T3.
cSignificantly different to RTB Day 1, T0.